Inhibitory effects of topical thymoquinone on corneal neovascularization

Cornea

Volumn 26, Issue 6, 2007, Pages 715-719

  Erdurmus, Mesut ^a   Yagci, Ramazan ^a   Yilmaz, Bulent ^b   Hepsen, Ibrahim F ^a   Turkmen, Cem ^b   Aydin, Bahri ^a   Karadag, Remzi ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Corneal neovascularization; Thymoquinone; Triamcinolone acetonide

Indexed keywords

KENAKORT A; POTASSIUM NITRATE; SILVER NITRATE; THYMOQUINONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CAUTERIZATION; COMPUTER PROGRAM; CONTROL GROUP; CONTROLLED STUDY; CORNEA; CORNEA NEOVASCULARIZATION; DRUG EFFICACY; DRUG INSTILLATION; INHIBITION KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BENZOQUINONES; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, WISTAR; TRIAMCINOLONE ACETONIDE;

EID: 34447530714     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31804f5a45     Document Type: Article

References (35)

1. Haynes WL, Proia AD, Klintworth GK. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci. 1989;30:1588-1593.
2. Rochels R. Animal experiment studies on the role of inflammation mediators in corneal neovascularization. Doc Ophthalmol. 1984;57:215-262.
3. Sala A, Zarini S, Bolla M. Leukotrienes: lipid bioeffectors of inflammatory reactions. Biochemistry (Mosc). 1998;63:84-92.
4. Epstein RJ, Stulting RD, Hendricks RL, et al. Corneal neovascularization. Pathogenesis and inhibition. Cornea. 1987;6:250-257.
5. Mahoney JM, Waterbury LD. Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res. 1985;4:531-535.
6. Folkman J, Weisz PB, Joullie MM. Control of angiogenesis with synthetic heparin substitutes. Science. 1989;243:1490-1493.
7. Yamada M, Kawai M, Kawai Y, et al. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat. Curr Eye Res. 1999;19:300-304.
8. Zhang Z, Ma JX, Gao G, et al. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization. Invest Ophthalmol Vis Sci. 2005;46:4062-4071
9. Murata M, Shimizu S, Horiuchi S, et al. Inhibitory effect of triamcinolone acetonide on corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2006;244:205-209.
10. Riazi-Esfahani M, Peyman GA, Aydin E, et al. Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model. Cornea. 2006;25:801-805.
11. Yoon KC, Ahn KY, Lee SE, et al. Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin. Curr Eye Res. 2006;31:215-224.
12. Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol. 2001;76:45-48.
13. Houghton PJ, Zarka R, de las Heras B, et al. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leucocytes and membrane lipid peroxidation. Planta Med. 1995;61:33-36.
14. Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res. 2000;14:323-328.
15. Kruk I, Michalska T, Lichszteld K, et al. The effect of thymol and its derivatives on reactions generating reactive oxygen species. Chemosphere. 2000;41:1059-1064.
16. Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006;38:1249-1253.
17. El-Mahmoudy A, Shimizu Y, Shiina T, et al. Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone. Acta Diabetol. 2005;42:23-30.
18. Marsik P, Kokoska L, Landa P, et al. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses. Planta Med. 2005;71:739-742.
19. Totan Y, Aydin E, Cekic O, et al. Effect of caffeic acid phenethyl ester on corneal neovascularization in rats. Curr Eye Res. 2001;23:291-297.
20. Gohto Y, Obana A, Kaneda K, et al. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization. Exp Eye Res. 1998;67:313-322.
21. Verbey NL, van Haeringen NJ, de Jong PT. Modulation of immunogenic keratitis in rabbits by topical administration of inhibitors of lipoxygenase and cyclooxygenase. Curr Eye Res. 1988;7:361-368.
22. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol. 2005;5:1749-1770.
23. Glatt HJ, Vu MT, Burger PC, et al. Effect of irradiation on vascularization of corneas grafted onto chorioallantoic membrane. Invest Ophthalmol Vis Sci. 1985;26:1533-1542.
24. Suvarnamani C, Halperin EC, Proia AD, et al. The effects of total lymphoid irradiation upon corneal vascularization in the rat following chemical cautery. Radiat Res. 1989;117:259-272.
25. Mayer M. Interferons, interleukins, virus-host interaction: relation to leukotrienes and other lipoxygenase derivatives of arachidonic acid. Acta Virol. 1990;34:99-107.
26. Bortuzzo C, Hanif R, Kashfi K, et al. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim Biophys Acta. 1996;1300:240-246.
27. Abramson S, Hoffstein ST, Weissmann G. Superoxide anion generation by human neutrophils exposed to monosodium urate. Arthritis Rheum. 1982;25:174-180.
28. Buddi R, Lin B, Atilano SR, et al. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002;50:341-351.
29. Laria C, Alio JL, Ruiz-Moreno JM. Combined nonsteroidal therapy in experimental corneal injury. Ophthalmic Res. 1997;29:145-153.
30. Monte M, Davel LE, de Lustig ES. Inhibition of lymphocyte-induced angiogenesis by free radical scavengers. Free Radic Biol Med. 1994;17:259-266.
31. Koch AE, Cho M, Burrows JC, et al. Inhibition of production of monocyte/macrophage-derived angiogenic activity by oxygen free-radical scavengers. Cell Biol Int Rep. 1992;16:415-425.
32. Badary OA, Taha RA, Gamal el-Din AM, et al. Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol. 2003;26:87-98.
33. Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med. 2004;10:143-145.
34. Fukumura D, Gohongi T, Kadambi A, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factorinduced angiogenesis and vascular permeability. Proc Natl Acad Sci USA. 2001;98:2604-2609.
35. El-Mahmoudy A, Matsuyama H, Borgan MA, et al. Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int Immunopharmacol. 2002;2:1603-1611.